英科醫療(300677.SZ):擬以自有資金5億元投資相關資管計劃
格隆匯6月18日丨英科醫療(300677.SZ)公佈,為提高公司閒置資金使用效率,提升投資價值,公司作為資產委託人、深圳平安匯通投資管理有限公司(“深圳平安匯通投資”或“資產管理人”)、平安銀行股份有限公司深圳分行(“深圳平安銀行”或“資產託管人”)擬簽訂《平安匯通天睿8號1期單一資產管理計劃資產管理合同》。公司與深圳平安匯通投資、深圳平安銀行成立平安匯通天睿8號1期單一資產管理計劃(“資管計劃”或“本計劃”),公司擬以自有資金5億元投資該資管計劃;該計劃存續期為自本資產管理計劃成立日起算,至起始運作日起的滿12個月之日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.